By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Naurex Inc. 

1801 Maple Avenue
Suite 4300
Evanston  Illinois  60201  U.S.A.
Phone: 317-250-3276 Fax: n/a



Start Up

Company News
Naurex Inc. Release: Data Presented At Society For Neuroscience Demonstrates That Naurex's GLYX-13 Enhances Synaptic Plasticity Through NMDA Receptor Modulation 11/17/2014 2:57:09 PM
Naurex Inc. To Present At UBS Global Healthcare Conference 5/15/2014 7:36:45 AM
Naurex Inc.'s Two Lead Antidepressant Candidates Achieve Major Milestones In Phase 2 Trials, Raises $25 Million 5/6/2014 6:30:44 AM
FDA Grants Fast Track Designation To Naurex Inc.'s Rapid-Acting Novel Antidepressant GLYX-13 3/3/2014 10:09:09 AM
Naurex Inc. To Present At Cowen and Company 34th Annual Health Care Conference 2/27/2014 6:43:43 AM
Naurex Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/10/2014 6:26:23 AM
Naurex Inc. Names Dr. Norbert G. Riedel President And Chief Executive Officer 1/8/2014 7:11:09 AM
Naurex Inc. Announces Issuance of New Patent for Novel Antidepressant GLYX-13 7/30/2013 9:01:57 AM
Naurex Inc. Announces Initiation of Phase I Trial for Second-Generation Novel Antidepressant Agent NRX-1074 6/4/2013 9:17:45 AM
Naurex Inc. Completes $38 Million Series B Financing 12/17/2012 7:41:09 AM